Cognitive impairment following breast cancer treatments: an umbrella review.

ABSTRACT:

Objectives

Cancer-related cognitive impairment (CRCI) refers to a cognitive decline associated with cancer or its treatments. While research into CRCI is expanding, evidence remains scattered due to differences in study designs, methodologies, and definitions. The present umbrella review aims to provide a comprehensive overview of the current evidence regarding the impact of different breast cancer therapies on cognitive functioning, with a particular focus on the interplay among objective cognitive deficits (ie, measured with standardized tests), subjective cognitive concerns, (ie, self-reported), and other mediating psycho-physical factors.

Methods

The search was made in Pubmed, Embase, and Scopus for articles published until July 2023, following the guidelines of the Pref

SUBMITTER: Oliva G 

PROVIDER: S-EPMC11224991 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature